Source link : https://newshealth.biz/health-news/duchenne-gene-therapy-will-undergo-changes-after-patient-deaths/
(MedPage Today) — At the FDA’s request, delandistrogene moxeparvovec (Elevidys), the only approved gene therapy for Duchenne muscular dystrophy, will carry a black box warning for acute liver injury and acute liver failure, drugmaker Sarepta Therapeutics… Source link : https://www.medpagetoday.com/neurology/generalneurology/116559 Author : Publish date : 2025-07-17 20:04:00 Copyright for syndicated content belongs to the linked […]
The post Duchenne Gene Therapy Will Undergo Changes After Patient Deaths first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-17 20:04:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8